BIT
GILD icon

BlackRock Institutional Trust’s Gilead Sciences GILD Stock Holding History

BlackRock Institutional Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,300
Closed -$588K – 3976
2014
Q1 		$588K Buy
+8,300
New +$651K ﹤0.01% 3540

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Institutional Trust's GILD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Gilead Sciences (GILD) stake by 1.2% in Q4 2016, buying an estimated $31.4M and bringing the position to 36,939,759 shares worth $2.65B. The position accounts for 0.39% of the portfolio, ranked #42.

BlackRock Institutional Trust first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.55B in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • BlackRock Institutional Trust held 36,939,759 shares of Gilead Sciences worth $2.65B as of Q4 2016.
  • BlackRock Institutional Trust bought 421,805 Gilead Sciences shares in Q4 2016, an estimated $31.4M.
  • Gilead Sciences made up 0.39% of BlackRock Institutional Trust's portfolio in Q4 2016, its #42 holding.
  • BlackRock Institutional Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Gilead Sciences position peaked at $4.55B in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.